Filing Flows › Stemtech (STEK) › Q1 2026
Stemtech (STEK) Q1 2026 earnings results (first quarter 2026)
10-Q filed Jun 22, 2026
Stemtech (STEK) reported revenue of $463K for the first quarter 2026 (Q1 2026), -47% from a year earlier and +1% from the quarter before. Operating margin was -236.4%, net loss $1.3M (270.6% of revenue).
Stemtech, Q1 2026: revenue $463K (-47% year over year), operating margin -236.4%, net loss $1.3M, operating cash flow −$426K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $463K | +1% | -47% |
| Operating profit | −$1.1M | — | — |
| Net earnings | −$1.3M | — | — |
| Operating cash flow | −$426K | -435% | — |
What changed
Revenue was $463K in Q1 2026, down 47% year over year and up 1% from the previous quarter.
Gross margin was 76.4%, down 6.6 points from Q1 2025. Operating costs exceeded revenue by $1.1M, an operating margin of -236.4%. Operating expenses fell 25% while revenue fell 47%. The quarter ended with a net loss of $1.3M, narrower than the previous quarter's $1.5M loss.
Operating cash flow was −$426K. Non-cash charges added back $42K of depreciation and amortization and $108K of share-based compensation. Working capital and other items added $677K.
Questions
What was Stemtech's revenue in the first quarter 2026?
Stemtech (STEK) reported revenue of $463K for the first quarter 2026 (Q1 2026), -47% from a year earlier and +1% from the quarter before.
Was Stemtech profitable in the first quarter 2026?
Operating loss was $1.1M (-236.4% of revenue) and net loss $1.3M.
Source: Stemtech 10-Q on SEC EDGAR.